Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline Deferred Investment Award Programme notified the Company and the under-mentioned persons on 16 July 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1750.75 pence per Share following the re-investment of the dividend paid to shareholders on 11 July 2013.
Mr S A Hussain |
271.623 |
Mr D S Redfern |
60.727 |
Ms C Thomas |
37.955 |
Ms E Walmsley |
558.474 |
Mrs V A Whyte |
148.121 |
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
16 July 2013